Oliver Seifert

15PUBLICATIONS
42CO-AUTHORS
BiomaterialsMolecular targetsAgricultural molecular engineering of nucleic acids and proteinsGlycoconjugatesMedical devices
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Sep 11, 2026
The FAP × CD3 bispecific antibody OMTX305 induces T cell-mediated antitumor effects in patient-derived ex vivo models of solid tumors.

|May 19, 2026
Novel bispecific T-cell engagers overcoming acquired EGFR resistance.

|Nov 25, 2023
Evaluation of the Neutralizing Antibody STE90-C11 against SARS-CoV-2 Delta Infection and Its Recognition of Other Variants of Concerns.

Leila Abassi, Federico Bertoglio, Željka Mačak Šafranko

|Mar 02, 2023
eIg-based bispecific T-cell engagers targeting EGFR: Format matters.

Lennart Kühl, Annelie K Schäfer, Sebastian Kraft

|May 28, 2022
GlycoTAIL and FlexiTAIL as Half-Life Extension Modules for Recombinant Antibody Fragments.

Oliver Seifert, Roland E Kontermann

|Apr 15, 2022
The eIg technology to generate Ig-like bispecific antibodies.

Lennart Kühl, Nadine Aschmoneit, Roland E Kontermann

Pageof 3

Frequent Collaborators

11 joint publications

Roland E Kontermann

6 joint publications

Lennart Kühl

5 joint publications

Monilola A Olayioye

5 joint publications

Nadine Beha